SCICLONE PHARMACEUTICALS, INC. STOCK OPTION AGREEMENTStock Option Agreement • November 9th, 2015 • Sciclone Pharmaceuticals Inc • Pharmaceutical preparations • California
SciClone Pharmaceuticals, Inc. (the “Company”) has granted to the Participant named in the Notice of Grant of Stock Option (the “Grant Notice”) to which this Stock Option Agreement (the “Option Agreement”) is attached an option (the “Option”) to purchase certain shares of Stock upon the terms and conditions set forth in the Grant Notice and this Option Agreement. The Option has been granted pursuant to and shall in all respects be subject to the terms and conditions of the SciClone Pharmaceuticals, Inc. 2015 Equity Incentive Plan (the “Plan”), as amended to the Date of Grant, the provisions of which are incorporated herein by reference. By signing the Grant Notice, the Participant: (a) acknowledges receipt of, and represents that the Participant has read and is familiar with, the Grant Notice, this Option Agreement, the Plan and a prospectus for the Plan prepared in connection with the registration with the Securities and Exchange Commission of shares issuable pursuant to the Option (t
SCICLONE PHARMACEUTICALS, INC. RESTRICTED STOCK UNITS AGREEMENTRestricted Stock Units Agreement • November 9th, 2015 • Sciclone Pharmaceuticals Inc • Pharmaceutical preparations • California
SciClone Pharmaceuticals, Inc. has granted to the Participant named in the Notice of Grant of Restricted Stock Units (the “Grant Notice”) to which this Restricted Stock Units Agreement (the “Agreement”) is attached an Award consisting of Restricted Stock Units (each a “Unit”) subject to the terms and conditions set forth in the Grant Notice and this Agreement. The Award has been granted pursuant to and shall in all respects be subject to the terms conditions of the SciClone Pharmaceuticals, Inc. 2015 Equity Incentive Plan (the “Plan”), as amended to the Date of Grant, the provisions of which are incorporated herein by reference. By signing the Grant Notice, the Participant: (a) acknowledges receipt of and represents that the Participant has read and is familiar with the Grant Notice, this Agreement, the Plan and a prospectus for the Plan prepared in connection with the registration with the Securities and Exchange Commission of the shares issuable pursuant to the Award (the “Plan Prosp
SCICLONE PHARMACEUTICALS, INC. EMPLOYEE RETENTION AGREEMENTEmployee Retention Agreement • November 9th, 2015 • Sciclone Pharmaceuticals Inc • Pharmaceutical preparations • California
This Employee Retention Agreement (the “Agreement”) is effective as of July 31, 2015, by and between Hong Zhao (“Employee”), SciClone Pharmaceuticals (China) Co., Ltd., a People’s Republic of China limited liability company, and SciClone Pharmaceuticals, Inc., a Delaware corporation (together, the “Company”). For all purposes under this Agreement, the term “Company” shall include any successor to the Company’s business and/or assets, or any subsidiary of the Company or its successor.
SCICLONE PHARMACEUTICALS, INC. RESTRICTED STOCK UNITS AGREEMENTRestricted Stock Units Agreement • November 9th, 2015 • Sciclone Pharmaceuticals Inc • Pharmaceutical preparations • California
SciClone Pharmaceuticals, Inc. has granted to the Participant named in the Notice of Grant of Restricted Stock Units (the “Grant Notice”) to which this Restricted Stock Units Agreement (the “Agreement”) is attached an Award consisting of Restricted Stock Units (each a “Unit”) subject to the terms and conditions set forth in the Grant Notice and this Agreement. The Award has been granted pursuant to and shall in all respects be subject to the terms conditions of the SciClone Pharmaceuticals, Inc. 2015 Equity Incentive Plan (the “Plan”), as amended to the Date of Grant, the provisions of which are incorporated herein by reference. By signing the Grant Notice, the Participant: (a) acknowledges receipt of and represents that the Participant has read and is familiar with the Grant Notice, this Agreement, the Plan and a prospectus for the Plan prepared in connection with the registration with the Securities and Exchange Commission of the shares issuable pursuant to the Award (the “Plan Prosp
SCICLONE PHARMACEUTICALS, INC. STOCK OPTION AGREEMENTStock Option Agreement • November 9th, 2015 • Sciclone Pharmaceuticals Inc • Pharmaceutical preparations • California
SciClone Pharmaceuticals, Inc. (the “Company”) has granted to the Participant named in the Notice of Grant of Stock Option (the “Grant Notice”) to which this Stock Option Agreement (the “Option Agreement”) is attached an option (the “Option”) to purchase certain shares of Stock upon the terms and conditions set forth in the Grant Notice and this Option Agreement. The Option has been granted pursuant to and shall in all respects be subject to the terms and conditions of the SciClone Pharmaceuticals, Inc. 2015 Equity Incentive Plan (the “Plan”), as amended to the Date of Grant, the provisions of which are incorporated herein by reference. By signing the Grant Notice, the Participant: (a) acknowledges receipt of, and represents that the Participant has read and is familiar with, the Grant Notice, this Option Agreement, the Plan and a prospectus for the Plan prepared in connection with the registration with the Securities and Exchange Commission of shares issuable pursuant to the Option (t
